Trials / Conditions / Stage IIIC Uterine Corpus Cancer AJCC v7

Stage IIIC Uterine Corpus Cancer AJCC v7

10 registered clinical trials studyying Stage IIIC Uterine Corpus Cancer AJCC v7.

Status	Trial	Sponsor	Phase
Terminated	Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Canc NCT03345784	National Cancer Institute (NCI)	Phase 1
Completed	Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid End NCT02684227	M.D. Anderson Cancer Center	Phase 2
Withdrawn	Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With NCT03902379	Rutgers, The State University of New Jersey	N/A
Completed	Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Und NCT02315469	NRG Oncology	—
Active Not Recruiting	Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi NCT01970722	City of Hope Medical Center	Phase 1
Unknown	Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or NCT02065687	Gynecologic Oncology Group	Phase 2 / Phase 3
Completed	Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer NCT01440998	National Cancer Institute (NCI)	Phase 1
Completed	Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Tr NCT01005329	National Cancer Institute (NCI)	Phase 2
Unknown	Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, NCT00942357	Gynecologic Oncology Group	Phase 3
Completed	Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With S NCT00063999	GOG Foundation	Phase 3